RNU6-104P

Across TCGA pan-cancer cohorts, RNU6-104P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated RNU6-104P data layer compared with 7 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-104P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-104P expression acts as an unfavorable survival marker.

BLCA, SKCM, and SARC are the cancer types where RNU6-104P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.017	0.720	<.001	24	view →
SKCM	OS	Median	All	0.377	0.788	.013	12	view →
SARC	OS	Median	All	0.151	0.730	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6-104P–BLCA (OS)

Open the BLCA breakdown →